Key Findings
A recent survey published in the Journal of the American Medical Association revealed that the use of CBD has increased by 50% over the past four years. Approximately 1 in 5 respondents reported using CBD in the past year. Interestingly, individuals who use cannabis are more likely to also use CBD, CBG, and other hemp-derived compounds, as per the survey conducted by NORC at the University of Chicago.
Delta-8 THC Raises Concerns
The survey also shed light on the fact that people residing in states where marijuana is illegal are more inclined to use delta-8 THC, a mildly intoxicating compound related to delta-9 THC, the psychoactive component of marijuana. Angela Bryan, a professor at the University of Colorado-Boulder, expressed concerns about the lack of data regarding the effects of these compounds, whether harmful or beneficial. She emphasized the need for further research in this area.
Popularity and Lack of Regulation
Since the legalization of hemp production in 2018, CBD and similar compounds have gained significant popularity. These compounds can be found in various products such as lotions, tinctures, candies, and vapes. However, there is a lack of government regulation surrounding these products. The U.S. Food and Drug Administration (FDA) did approve one CBD-containing drug in 2018 for the treatment of rare seizure disorders. Nevertheless, experts caution that there is insufficient clinical research on these compounds. The FDA has also issued a warning highlighting the potential for liver injury and adverse interactions with certain medications.
Delta-8 THC: Cause for Concern
Of particular concern is delta-8 THC due to its adverse side effects and the way it is chemically manufactured. While some states, including Colorado, have banned or regulated delta-8 THC, it is still being sold in many states due to a loophole in federal law. Angela Bryan suggested that individuals who lack access to legal delta-9 THC may turn to delta-8 as an alternative, further highlighting the need for research on this compound.
“The implication in the paper, and I think it’s accurate, is that if you don’t have access to legal delta-9, then you’re going to seek out delta-8,” Bryan stated. “But we know even less about delta-8 than we do about delta-9.”
The survey results underscore the pressing need for comprehensive research on the effects and potential risks associated with CBD, CBG, and other hemp-derived compounds. Without reliable data, it becomes challenging to assess their overall impact on public health.